Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Molecular Nutrition & Food Research|January 16, 2026
Salvianolic Acid A Protects Against Angiotensin II-Induced Hypertensive Kidney Disease by Targeting TLR4 and Inhibiting TLR4/Myd88/PI3K/AKT/NF-κB PathwayWenhan Wang, Ji Zhang, Jianghua Zhou, et al.
Molecular Medicine Reports|May 30, 2020
Downregulated miR‑29a promotes B cell overactivation by upregulating Crk‑like protein in systemic lupus erythematosusXinyu Shi, Lulu Ye, Shuqi Xu, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|February 7, 2021
A Review of the Current Practice of Diagnosis and Treatment of Idiopathic Membranous Nephropathy in ChinaLianzhong Wu, Jin Lai, Yixin Ling, et al.
Research Square|December 23, 2024
InTraSeq: A Multimodal Assay that Uncovers New Single-Cell Biology and Regulatory MechanismsSean Beausoleil, Majd Ariss, Linglin Huang, et al.
Rheumatology (Oxford, England)|December 25, 2023
Efficacy and safety of belimumab in patients with lupus nephritis: a real-world retrospective observational studySishi Lin, Ji Zhang, Xiaohan You, et al.
Epigenomics|July 18, 2020
TCONS_00483150 as a novel diagnostic biomarker of systemic lupus erythematosusGangqiang Guo, Aqiong Chen, Lele Ye, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2024
Mediator kinase inhibitors suppress triple-negative breast cancer growth and extend tumor suppression by mTOR and AKT inhibitorsXiaokai Ding, Jiaxin Liang, Amanda C Sharko, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2022
Inhibition of CDK8/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in vitro and in vivoXiaokai Ding, Amanda C Sharko, Martina S J McDermott, et al.
Nucleic Acids Research|June 28, 2023
CDK8 and CDK19: positive regulators of signal-induced transcription and negative regulators of Mediator complex proteinsMengqian Chen, Jing Li, Li Zhang, et al.
The Journal of Clinical Investigation|March 28, 2024
Mediator kinase inhibition reverses castration resistance of advanced prostate cancerJing Li, Thomas A Hilimire, Yueying Liu, et al.
Pageof 4